Ulugol Halim, Aksu Ugur, Kocyigit Muharrem, Kilercik Meltem, Karduz Gulsum, Okten Murat, Toraman Fevzi
Department of Anesthesiology and Reanimation, Acibadem University, School of Medicine, Istanbul, Turkey.
Department of Biology, Science Faculty, Istanbul University, Istanbul, Turkey.
Ann Thorac Cardiovasc Surg. 2019 Feb 20;25(1):10-17. doi: 10.5761/atcs.oa.18-00113. Epub 2018 Aug 28.
The purpose of this study was to evaluate the effect of different cardioplegic solutions on endothelial integrity and oxidative stress in cardiovascular surgery.
In this randomized prospective study, after ethics approval and informed consent, 60 surgical patients were included. Patients undergoing coronary bypass surgery were randomized into two groups as warm blood cardioplegia (n = 30) and cold crystalloid cardioplegia (n = 30) following the cross-clamping. Measurements were performed at three time points: before induction of anesthesia (T1), at admission to intensive care unit (ICU) (T2) and at the 24th postoperative hour (T3). Besides biochemical routine hemodynamic monitoring, patients were assessed for the sialic acid (SA), ischemic-modified albumin (IMA), advanced oxide protein products (AOPPs), total thiol (SH), and free hemoglobin (fHb) level.
Neither crystalloid nor blood cardioplegia led to significant changes in the AOPPs, T-SH, and SA level (p >0.05). Crystalloid cardioplegia, however, increased IMA level compared to both baseline (p <0.01) and blood cardioplegia group (p <0.05). fHb levels were transiently increased in both groups at the second-time point (p <0.001). fHb level was lower in the crystalloid group compared to that in the other group (p <0.05) at T2.
Cardioplegia type creates similar effects on glycocalyx integrity. However, myocardial protection could be provided with warm blood cardioplegia.
本研究旨在评估不同心脏停搏液对心血管手术中内皮完整性和氧化应激的影响。
在这项随机前瞻性研究中,经伦理批准并获得知情同意后,纳入了60例手术患者。接受冠状动脉搭桥手术的患者在主动脉阻断后被随机分为两组,即温血心脏停搏液组(n = 30)和冷晶体心脏停搏液组(n = 30)。在三个时间点进行测量:麻醉诱导前(T1)、重症监护病房(ICU)入院时(T2)和术后第24小时(T3)。除了进行生化常规血流动力学监测外,还评估了患者的唾液酸(SA)、缺血修饰白蛋白(IMA)、晚期氧化蛋白产物(AOPPs)、总巯基(SH)和游离血红蛋白(fHb)水平。
晶体心脏停搏液和血液心脏停搏液均未导致AOPPs、总巯基(T-SH)和SA水平发生显著变化(p>0.05)。然而,与基线相比(p< \n0.01)以及与血液心脏停搏液组相比(p<0.05),晶体心脏停搏液使IMA水平升高。两组在第二个时间点的fHb水平均短暂升高(p<0.001)。在T2时,晶体组的fHb水平低于另一组(p<0.05)。
心脏停搏液类型对糖萼完整性产生相似的影响。然而,温血心脏停搏液可提供心肌保护。